Subtopic Deep Dive
Nuclear Receptors in Drug Transporter Regulation
Research Guide
What is Nuclear Receptors in Drug Transporter Regulation?
Nuclear receptors such as PXR, CAR, and FXR transcriptionally regulate ABC drug transporters in response to xenobiotics and bile acids, influencing drug transport and resistance.
PXR and CAR activate ABC transporters like BSEP/SPGP upon xenobiotic exposure (Schuetz et al., 2001, 386 citations). FXR modulates bile acid homeostasis by regulating transporters and cytochrome P450 enzymes (Edwards et al., 2002, 384 citations; Li and Chiang, 2014, 873 citations). Over 20 papers detail these mechanisms, with Klaassen and Aleksunes (2010, 789 citations) reviewing regulation comprehensively.
Why It Matters
Nuclear receptor regulation explains inter-individual variability in drug pharmacokinetics and chemotherapy resistance, as transporters like ABCC2 reduce intracellular drug levels (Nies and Keppler, 2006, 387 citations). In oncology, PXR induction by xenobiotics promotes multidrug resistance (Shen et al., 2012, 945 citations). FXR activation impacts bile acid-related therapies for metabolic diseases (Li and Chiang, 2014). These interactions predict drug-drug interactions, guiding precision dosing (Klaassen and Aleksunes, 2010).
Key Research Challenges
Transducer Ligand Specificity
PXR, CAR, and FXR respond to overlapping xenobiotics and bile acids with varying potency, complicating prediction of transporter induction (Schuetz et al., 2001). Hierarchy of bile acids as FXR ligands parallels BSEP expression variability across livers. Tissue-specific differences challenge generalized models (Klaassen and Aleksunes, 2010).
Inter-Individual Expression Variability
BSEP/SPGP and ABCC2 expression varies dramatically among human livers due to nuclear receptor polymorphisms (Schuetz et al., 2001, 386 citations). Genetic and epigenetic changes amplify resistance via transporter upregulation (Shen et al., 2012, 945 citations). Modeling population-level impacts remains unresolved.
Drug-Drug Interaction Prediction
Xenobiotics induce transporters via PXR/CAR, leading to reduced efficacy of co-administered drugs (Klaassen and Aleksunes, 2010). FXR disruption reveals unexpected P450-transporter crosstalk (Schuetz et al., 2001). Integrating signaling pathways like PI3K/AKT for comprehensive MDR models is challenging (Liu et al., 2020).
Essential Papers
Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes
Ding‐Wu Shen, Lynn M. Pouliot, Matthew D. Hall et al. · 2012 · Pharmacological Reviews · 945 citations
Bile Acid Signaling in Metabolic Disease and Drug Therapy
Tiangang Li, John Y.L. Chiang · 2014 · Pharmacological Reviews · 873 citations
PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
Rui Liu, Youwen Chen, Guangzhi Liu et al. · 2020 · Cell Death and Disease · 865 citations
Abstract Multidrug resistance (MDR) is the dominant challenge in the failure of chemotherapy in cancers. Phosphatidylinositol 3-kinase (PI3K) is a lipid kinase that spreads intracellular signal cas...
Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation
Curtis D. Klaassen, Lauren M. Aleksunes · 2010 · Pharmacological Reviews · 789 citations
Bile acids: Chemistry, physiology, and pathophysiology
María J. Monte, José J.G. Marı́n, Álvaro Antelo et al. · 2009 · World Journal of Gastroenterology · 549 citations
The family of bile acids includes a group of molecular species of acidic steroids with very peculiar physical-chemical and biological characteristics. They are synthesized by the liver from cholest...
Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences
Zoran Redzic · 2011 · Fluids and Barriers of the CNS · 404 citations
The apical conjugate efflux pump ABCC2 (MRP2)
Anne T. Nies, Dietrich Keppler · 2006 · Pflügers Archiv - European Journal of Physiology · 387 citations
Reading Guide
Foundational Papers
Start with Klaassen and Aleksunes (2010, 789 citations) for comprehensive transporter regulation overview, then Schuetz et al. (2001, 386 citations) for FXR-BSEP interactions revealing nuclear receptor-transporter-P450 networks.
Recent Advances
Li and Chiang (2014, 873 citations) on bile acid signaling; Liu et al. (2020, 865 citations) linking PI3K to MDR with transporter roles.
Core Methods
Ligand binding assays for receptor activation; qPCR/Western blots for transporter expression; siRNA knockdown to confirm causality (Nies and Keppler, 2006).
How PapersFlow Helps You Research Nuclear Receptors in Drug Transporter Regulation
Discover & Search
Research Agent uses searchPapers and exaSearch to find 250M+ OpenAlex papers on 'PXR CAR FXR ABC transporters', then citationGraph reveals Schuetz et al. (2001) as a hub connecting FXR/BSEP regulation to 386 citing works. findSimilarPapers expands to related FXR studies like Edwards et al. (2002).
Analyze & Verify
Analysis Agent applies readPaperContent to extract FXR ligand hierarchies from Schuetz et al. (2001), verifies claims with CoVe against Klaassen and Aleksunes (2010), and runs PythonAnalysis to plot transporter expression correlations across 10 papers using pandas on citation metadata. GRADE assigns high evidence to PXR induction mechanisms.
Synthesize & Write
Synthesis Agent detects gaps in FXR-ABCC2 interactions post-2014, flags contradictions between bile acid signaling papers. Writing Agent uses latexEditText for figure legends, latexSyncCitations to integrate 20 refs, and latexCompile for a review manuscript; exportMermaid diagrams PXR-CAR signaling cascades.
Use Cases
"Extract dose-response data for rifampicin on PXR-induced BSEP from human liver papers."
Research Agent → searchPapers → Analysis Agent → readPaperContent (Schuetz et al., 2001) → runPythonAnalysis (NumPy curve fitting on EC50 values) → matplotlib dose-response plot.
"Write LaTeX section on FXR regulation of ABCC2 with citations."
Research Agent → citationGraph (Nies and Keppler, 2006 hub) → Synthesis → gap detection → Writing Agent → latexEditText → latexSyncCitations (10 refs) → latexCompile → PDF output.
"Find GitHub repos with PXR simulation models from transporter papers."
Research Agent → paperExtractUrls (Klaassen 2010) → Code Discovery → paperFindGithubRepo → githubRepoInspect → verified PK simulation code.
Automated Workflows
Deep Research workflow scans 50+ papers on nuclear receptors via searchPapers → citationGraph, producing a structured report with GRADE-scored sections on PXR xenobiotic induction. DeepScan applies 7-step CoVe checkpoints to verify FXR-BSEP claims across Schuetz et al. (2001) and Li/Chiang (2014). Theorizer generates hypotheses on CAR polymorphisms from expression variability data.
Frequently Asked Questions
What defines nuclear receptors in drug transporter regulation?
PXR, CAR, and FXR are ligand-activated transcription factors that bind xenobiotics/bile acids to induce ABC transporters like BSEP and ABCC2 (Klaassen and Aleksunes, 2010).
What are key methods to study these mechanisms?
Chromatin immunoprecipitation identifies receptor binding sites on transporter promoters; luciferase assays quantify transcriptional activation (Schuetz et al., 2001); human hepatocyte models assess induction (Edwards et al., 2002).
What are seminal papers?
Schuetz et al. (2001, J Biol Chem, 386 citations) shows FXR-BSEP disruption; Klaassen and Aleksunes (2010, Pharmacol Rev, 789 citations) reviews all transporters; Li and Chiang (2014, 873 citations) covers bile acid signaling.
What open problems exist?
Predicting tissue-specific induction hierarchies; integrating genetic variants into PK models; resolving PXR/CAR crosstalk in MDR (Liu et al., 2020).
Research Drug Transport and Resistance Mechanisms with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Nuclear Receptors in Drug Transporter Regulation with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers